Rajan P Kulkarni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rajan P Kulkarni has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Finbarr Livesey
Department of Politics and International Studies University of Cambridge UK
1 shared publication Laure Dodin
University of Cambridge, Centre for Economics and Policy, Institute for Manufacturing, Cambridge, CB2 1RXUK
1 shared publication
Latest Publications
- 1 September 2007
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 2 (5) , 839-844
Will regulation determine the science agenda? A look at hESCs
Given the significant controversy over human embryonic stem cell (hESC) isolation and research, regulation of such work around the world has proceeded in an uncoordinated manner. In general, advances in science cause a need or desire for regulation; however, it has been the opposite for hESC research--regulation and policy have set certain boundaries for scientific research and defined other research questions. This is especially evident in the USA, where federal funding policies have engendered specific research towards novel methods for isolating such cells that do not require destruction of human embryos. Due to the multiplicity of national policies, it will be almost impossible to reach global consensus in the near future. Nonetheless, this paradigm of regulation leading science may have significant implications for future research projects. Changes in hESC policy in the short term will influence longer-term research potential.
- 1 September 2007
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 2 (5) , 839-844
Will regulation determine the science agenda? A look at hESCs
Given the significant controversy over human embryonic stem cell (hESC) isolation and research, regulation of such work around the world has proceeded in an uncoordinated manner. In general, advances in science cause a need or desire for regulation; however, it has been the opposite for hESC research--regulation and policy have set certain boundaries for scientific research and defined other research questions. This is especially evident in the USA, where federal funding policies have engendered specific research towards novel methods for isolating such cells that do not require destruction of human embryos. Due to the multiplicity of national policies, it will be almost impossible to reach global consensus in the near future. Nonetheless, this paradigm of regulation leading science may have significant implications for future research projects. Changes in hESC policy in the short term will influence longer-term research potential.
- Open Access
- 1 January 2007
- Published by Springer Nature in Journal of Biomedical Discovery and Collaboration
- Vol. 2 (1) , 3
Nano-Bio-Genesis: tracing the rise of nanotechnology and nanobiotechnology as 'big science'
Nanotechnology research has lately been of intense interest because of its perceived potential for many diverse fields of science. Nanotechnology's tools have found application in diverse fields, from biology to device physics. By the 1990s, there was a concerted effort in the United States to develop a national initiative to promote such research. The success of this effort led to a significant influx of resources and interest in nanotechnology and nanobiotechnology and to the establishment of centralized research programs and facilities. Further government initiatives (at federal, state, and local levels) have firmly cemented these disciplines as 'big science,' with efforts increasingly concentrated at select laboratories and centers. In many respects, these trends mirror certain changes in academic science over the past twenty years, with a greater emphasis on applied science and research that can be more directly utilized for commercial applications.
- 1 January 2007
- Published by Springer Nature in Journal of Biomedical Discovery and Collaboration
- Vol. 2 (1) , 3
Open AccessNano-Bio-Genesis: tracing the rise of nanotechnology and nanobiotechnology as 'big science'
Nanotechnology research has lately been of intense interest because of its perceived potential for many diverse fields of science. Nanotechnology's tools have found application in diverse fields, from biology to device physics. By the 1990s, there was a concerted effort in the United States to develop a national initiative to promote such research. The success of this effort led to a significant influx of resources and interest in nanotechnology and nanobiotechnology and to the establishment of centralized research programs and facilities. Further government initiatives (at federal, state, and local levels) have firmly cemented these disciplines as 'big science,' with efforts increasingly concentrated at select laboratories and centers. In many respects, these trends mirror certain changes in academic science over the past twenty years, with a greater emphasis on applied science and research that can be more directly utilized for commercial applications.